Orange Belgium S.A. (0FBS)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 22.15 |
|---|---|
| 52-week range | 16.25 – 22.30 |
| Return, 1 month / 3 months | +0.5% / +1.6% |
| Return, 1 year / 3 years | +16.0% / +45.2% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 6.2% |
| Worst drawdown (1 year) | -1.9% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Orange Belgium is a telecommunications operator serving customers in Belgium. It provides mobile voice and data services, fixed-line telephony, broadband internet and television packages, mainly to residential customers and to businesses of various sizes. The company also offers bundled services combining mobile and fixed products. It operates as part of the Orange group and is based in Belgium, where it runs its own network infrastructure and sells through its own shops and other channels.
Orange Belgium S.A. trades under the code 0FBS on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Orange Belgium S.A. (0FBS) trades on the London Exchange in UK. It last closed at EUR 22.15 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 860 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.0% and over the last three months it rose 1.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.4% | ||
| From 52-week high | -0.4% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.6% | ||
| 6-month return | 7.0% | ||
| 12-month return, skipping the last month | 15.4% | ||
| Stability (higher is calmer) | 98 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 6.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -1.9% | ||
| Liquidity | 2 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 90.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.5% |
| 3 months | +1.6% |
| 6 months | +7.0% |
| 1 year | +16.0% |
| 3 years | +45.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 22.08 / 21.02 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jun 2021 | EUR 0.3500 |
| 12 May 2020 | EUR 0.3500 |
| 14 May 2019 | EUR 0.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.